As on Thursday, Co-Diagnostics Inc (NASDAQ: CODX) started slowly as it slid -3.15% to $0.28, before settling in for the price of $0.29 at the close. Taking a more long-term approach, CODX posted a 52-week range of $0.23-$2.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -27.40% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -27.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 13.71%. This publicly-traded company’s shares outstanding now amounts to $33.57 million, simultaneously with a float of $30.68 million. The organization now has a market capitalization sitting at $9.34 million. At the time of writing, stock’s 50-day Moving Average stood at $0.3012, while the 200-day Moving Average is $0.6969.
Co-Diagnostics Inc (CODX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Co-Diagnostics Inc’s current insider ownership accounts for 9.00%, in contrast to 17.44% institutional ownership.
Co-Diagnostics Inc (CODX) Earnings and Revenue Records
Co-Diagnostics Inc’s EPS increase for this current 12-month fiscal period is 13.71% and is forecasted to reach -0.42 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 37.69% through the next 5 years, which can be compared against the -27.40% growth it accomplished over the previous five years trading on the market.
Co-Diagnostics Inc (NASDAQ: CODX) Trading Performance Indicators
Let’s observe the current performance indicators for Co-Diagnostics Inc (CODX). It’s Quick Ratio in the last reported quarter now stands at 4.23. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.39.
In the same vein, CODX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.14, a figure that is expected to reach -0.62 in the next quarter, and analysts are predicting that it will be -0.42 at the market close of one year from today.
Technical Analysis of Co-Diagnostics Inc (CODX)
Through scrutinizing the latest numbers posted by the [Co-Diagnostics Inc, CODX], it can be observed that its last 5-days Average volume of 0.28 million was lower the volume of 0.31 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 60.67% While, its Average True Range was 0.0269.
Raw Stochastic average of Co-Diagnostics Inc (CODX) in the period of the previous 100 days is set at 9.86%, which indicates a major fall in contrast to 54.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 59.73% that was lower than 87.53% volatility it exhibited in the past 100-days period.
